Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
- PMID: 10836145
- DOI: 10.1146/annurev.pharmtox.40.1.491
Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators
Abstract
Peroxisome proliferators (PPs) are a large class of structurally dissimilar chemicals that have diverse effects in rodents and humans. Most, if not all, of the diverse effects of PPs are mediated by three members of the nuclear receptor superfamily called peroxisome proliferator-activated receptors (PPARs). In this review, we define the molecular mechanisms of PPs, including PPAR binding specificity, alteration of gene expression through binding to DNA response elements, and cross talk with other signaling pathways. We discuss the roles of PPARs in growth promotion in rodent hepatocarcinogenesis and potential therapeutic effects, including suppression of cancer growth and inflammation.
Similar articles
-
Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.Mutat Res. 2000 Mar 17;448(2):139-51. doi: 10.1016/s0027-5107(99)00232-8. Mutat Res. 2000. PMID: 10725468 Review.
-
PPAR: a mediator of peroxisome proliferator action.Mutat Res. 1995 Dec;333(1-2):101-9. doi: 10.1016/0027-5107(95)00136-0. Mutat Res. 1995. PMID: 8538617 Review.
-
Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.Minerva Urol Nefrol. 2002 Jun;54(2):65-79. Minerva Urol Nefrol. 2002. PMID: 12185990 Review.
-
Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.Subcell Biochem. 2013;69:77-99. doi: 10.1007/978-94-007-6889-5_5. Subcell Biochem. 2013. PMID: 23821144 Review.
-
Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.Cancer Res. 2003 Sep 15;63(18):5767-80. Cancer Res. 2003. PMID: 14522898
Cited by
-
Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's disease.Theranostics. 2024 Sep 16;14(16):6088-6108. doi: 10.7150/thno.96707. eCollection 2024. Theranostics. 2024. PMID: 39431021 Free PMC article.
-
Herpetrione, a New Type of PPARα Ligand as a Therapeutic Strategy Against Nonalcoholic Steatohepatitis.Research (Wash D C). 2023 Nov 30;6:0276. doi: 10.34133/research.0276. eCollection 2023. Research (Wash D C). 2023. PMID: 38034083 Free PMC article.
-
Association of PCSK1 and PPARG1 Allelic Variants with Obesity and Metabolic Syndrome in Mexican Adults.Genes (Basel). 2023 Sep 8;14(9):1775. doi: 10.3390/genes14091775. Genes (Basel). 2023. PMID: 37761915 Free PMC article.
-
Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion.BMC Res Notes. 2023 Sep 11;16(1):202. doi: 10.1186/s13104-023-06489-7. BMC Res Notes. 2023. PMID: 37697384 Free PMC article.
-
NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer.Mol Med. 2023 Jul 3;29(1):87. doi: 10.1186/s10020-023-00673-y. Mol Med. 2023. PMID: 37400769 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
